ACAD vs. ABBV
Compare and contrast key facts about ACADIA Pharmaceuticals Inc. (ACAD) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ACAD or ABBV.
Correlation
The correlation between ACAD and ABBV is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ACAD vs. ABBV - Performance Comparison
Key characteristics
ACAD:
-0.46
ABBV:
0.64
ACAD:
-0.36
ABBV:
0.96
ACAD:
0.95
ABBV:
1.15
ACAD:
-0.29
ABBV:
0.83
ACAD:
-0.61
ABBV:
1.93
ACAD:
35.78%
ABBV:
8.21%
ACAD:
47.39%
ABBV:
24.73%
ACAD:
-96.29%
ABBV:
-45.09%
ACAD:
-65.49%
ABBV:
-2.29%
Fundamentals
ACAD:
$3.27B
ABBV:
$348.39B
ACAD:
$0.78
ABBV:
$2.39
ACAD:
25.22
ABBV:
82.57
ACAD:
-0.42
ABBV:
2.63
ACAD:
$698.20M
ABBV:
$56.33B
ACAD:
$638.16M
ABBV:
$41.47B
ACAD:
$85.39M
ABBV:
$18.15B
Returns By Period
In the year-to-date period, ACAD achieves a 7.19% return, which is significantly lower than ABBV's 12.11% return. Over the past 10 years, ACAD has underperformed ABBV with an annualized return of -6.25%, while ABBV has yielded a comparatively higher 17.22% annualized return.
ACAD
7.19%
11.95%
23.48%
-20.85%
-15.36%
-6.25%
ABBV
12.11%
15.03%
2.18%
16.39%
20.82%
17.22%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ACAD vs. ABBV — Risk-Adjusted Performance Rank
ACAD
ABBV
ACAD vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ACADIA Pharmaceuticals Inc. (ACAD) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ACAD vs. ABBV - Dividend Comparison
ACAD has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 3.19%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ACAD ACADIA Pharmaceuticals Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ABBV AbbVie Inc. | 3.19% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
ACAD vs. ABBV - Drawdown Comparison
The maximum ACAD drawdown since its inception was -96.29%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for ACAD and ABBV. For additional features, visit the drawdowns tool.
Volatility
ACAD vs. ABBV - Volatility Comparison
ACADIA Pharmaceuticals Inc. (ACAD) has a higher volatility of 11.68% compared to AbbVie Inc. (ABBV) at 7.34%. This indicates that ACAD's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ACAD vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between ACADIA Pharmaceuticals Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities